Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature

Canadian Journal of Surgery

Volumn 54, Issue 5, 2011, Pages 321-326

  Bailey, Chris S ^a   Fehlings, Michael G ^b   Rampersaud, Y Raja ^b   Hall, Hamilton ^b   Wai, Eugene K ^c   Fisher, Charles G ^d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053244414     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.008610     Document Type: Review

References (35)

1. Schünemann HJ, Jaeschke R, Cook DJ, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605-14. (Pubitemid 44330555)
2. Emanuel EJ, Schnipper LE, Kamin DY, et al. The costs of conducting clinical research. J Clin Oncol 2003;21:4145-50. (Pubitemid 46606182)
3. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289:454-65. (Pubitemid 36119966)
4. Zuckerman JD, Prasarn M, Kubiak EN, et al. Conflict of interest in orthopaedic research. J Bone Joint Surg Am 2004;86-A:423-8. (Pubitemid 38141582)
5. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med 1996;124:485-9. (Pubitemid 26070113)
6. Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med 1986;1:155-8.
7. Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 2002;325:249.
8. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70. (Pubitemid 36649048)
9. Als-Nielsen B, Chen W, Gluud C, et al. Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA 2003;290:921-8. (Pubitemid 37430464)
10. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturersupported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 1994;154:157-63.
11. Thompson DF. Understanding financial conflicts of interest. N Engl J Med 1993;329:573-6. (Pubitemid 23232630)
12. Mirza SK. Accountability of the accused: facing public perceptions about financial conflicts of interest in spine surgery. Spine J 2004;4:491-4. (Pubitemid 40029164)
13. Finucane TE, Boult CE. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med 2004;117:842-5. (Pubitemid 39602793)
14. Montgomery JH, Byerly M, Carmody T, et al. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Control Clin Trials 2004;25:598-612. (Pubitemid 39592864)
15. Leopold SS, Warme WJ, Fritz BE, et al. Association between funding source and study outcome in orthopaedic research. Clin Orthop Relat Res 2003; (415):293-301. (Pubitemid 37329067)
16. Okike K, Kocher MS, Mehlman CT, et al. Conflict of interest in orthopaedic research. An association between findings and funding in scientific presentations. J Bone Joint Surg Am 2007;89:608-13. (Pubitemid 46365361)
17. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004;170:477-80. (Pubitemid 38293642)
18. Ezzet KA. The prevalence of corporate funding in adult lower extremity research and its correlation with reported results. J Arthroplasty 2003;18(Suppl 1):138-45. (Pubitemid 37259679)
19. Lynch JR, Cunningham MR, Warme WJ, et al. Commercially funded and United States-based research is more likely to be published; good-quality studies with negative outcomes are not. J Bone Joint Surg Am 2007;89:1010-8. (Pubitemid 46724591)
20. Shah RV, Albert TJ, Bruegel-Sanchez V, et al. Industry support and correlation to study outcome for papers published in Spine. Spine 2005;30:1099-104. (Pubitemid 40663920)
21. Cunningham MR, Warme WJ, Schaad DC, et al. Industry-funded positive studies not associated with better design or larger size. Clin Orthop Relat Res 2007;457:235-41. (Pubitemid 46573421)
22. Foster RS. Conflicts of interest: recognition, disclosure, and management. J Am Coll Surg 2003;196:505-17.
23. Habal MB. The new science of craniofacial surgery in the form of research and development in the corporate world. J Craniofac Surg 2007;18:245-7. (Pubitemid 46597488)
24. Jones JW, McCullough LB. Surgeon-industry relationships: ethically responsible management of conflicts of interest. J Vasc Surg 2002; 35:825-6.
25. McKneally MF. Beyond disclosure: managing conflicts of interest to strengthen trust in our profession. J Thorac Cardiovasc Surg 2007; 133: 300-2. (Pubitemid 46136257)
26. Rohrich RJ. Plastic surgery journals: a meeting of minds in Berlin. Plast Reconstr Surg 2007;120:2101-5. (Pubitemid 350306717)
27. Sade RM, McKneally M. Responsibilities of investigators. Ann Thorac Surg 2002;73:1364-5. (Pubitemid 34596555)
28. White AP, Vaccaro AR, Zdeblick T. Counterpoint: physician-industry relationships can be ethically established, and conflicts of interest can be ethically managed. Spine 2007;32(Suppl):S53-7. (Pubitemid 46733672)
29. Djulbegovic B, Lacevic M, Cantor A, et al. The uncertainty principle and industry-sponsored research. Lancet 2000;356:635-8. (Pubitemid 30627590)
30. Hirsch L. Randomized clinical trials: What gets published, and when? CMAJ 2004;170:481-3. (Pubitemid 38293643)
31. Blumenthal D, Campbell EG, Anderson MS, et al. Withholding research results in academic life science. Evidence from a national survey of faculty. JAMA 1997;277:1224-8. (Pubitemid 27172746)
32. Boyd K. Early discontinuation violates Helsinki principles [commentary]. BMJ 2001;322:605-6. (Pubitemid 32234543)
33. Lièvre M, Menard J, Bruckert E, et al. Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ 2001;322:603-5. (Pubitemid 32234542)
34. Rennie D. Thyroid storm. JAMA 1997;277:1238-43.
35. Khan MH, Lee JY, Rihn JA, et al. The surgeon as a consultant for medical device manufacturers: What do our patients think? Spine 2007;32:2616-8. (Pubitemid 350059491)